Louisiana 2025 Regular Session

Louisiana House Bill HB112 Latest Draft

Bill / Introduced Version

                            HLS 25RS-537	ORIGINAL
2025 Regular Session
HOUSE BILL NO. 112
BY REPRESENTATIVE EDMONSTON
Prefiled pursuant to Article III, Section 2(A)(4)(b)(i) of the Constitution of Louisiana.
DRUGS/PRESCRIPTION:  Provides relative to the prescribing, administering, and
dispensing of drugs for off-label use
1	AN ACT
2To enact R.S. 37:1704, relative to prescribing, administering, and dispensing prescription
3 drugs; to provide for prescription, administration, and dispensing of certain drugs for
4 off-label use by healthcare professionals with prescriptive authority; to prohibit
5 certain licensing boards or commissions from limiting prescribing practices; and to
6 provide for related matters.
7Be it enacted by the Legislature of Louisiana:
8 Section 1.  R.S. 37:1704 is hereby enacted to read as follows:
9 ยง1704.  Prescription, administration, and dispensing of FDA-approved drugs for
10	off-label use
11	A.  As used in this Section, the following terms have the following meanings:
12	(1)  "FDA" means the United States Food and Drug Administration.
13	(2)  "Off-label use" means the use of a prescription drug for an indication for
14 which it has not been approved by the FDA or the use of such drug in an age group,
15 dosage, or route of administration that has not been approved by the FDA.
16	B.  No healthcare professional licensing board or commission created by the
17 provisions of this Title shall prohibit or restrict the prescribing, administering, or
18 dispensing for an off-label use of a drug that has been approved for a specific use by
19 the FDA.
Page 1 of 2
CODING:  Words in struck through type are deletions from existing law; words underscored
are additions. HLS 25RS-537	ORIGINAL
HB NO. 112
DIGEST
The digest printed below was prepared by House Legislative Services.  It constitutes no part
of the legislative instrument.  The keyword, one-liner, abstract, and digest do not constitute
part of the law or proof or indicia of legislative intent.  [R.S. 1:13(B) and 24:177(E)]
HB 112 Original 2025 Regular Session	Edmonston
Abstract:  Provides that no healthcare professional licensing board or commission of the
state shall prohibit or restrict the prescribing, administering, or dispensing of drugs
for off-label use.
Present law provides for licensure and regulation by the state of various types of healthcare
professionals.
Proposed law retains present law and provides that no healthcare professional licensing
board or commission shall prohibit or restrict the prescribing, administering, or dispensing
for an off-label use of a human drug that has been approved for a specific use by the U.S.
Food and Drug Administration (FDA).
Proposed law defines "off-label use", for purposes of proposed law, as the use of a
prescription drug for an indication for which it has not been approved by the FDA or the use
of such drug in an age group, dosage, or route of administration that has not been approved
by the FDA.
(Adds R.S. 37:1704)
Page 2 of 2
CODING:  Words in struck through type are deletions from existing law; words underscored
are additions.